Recent research shared in Medscape reveals that Americans have made little progress in reducing arthritis-related activity and work limitations. The abstract underscores a critical point: musculoskeletal (MSK) conditions remain one of the leading causes of disability, impacting daily life, productivity, and overall well-being.
Arthritis and MSK impact millions of Americans and without effective care models, they can lead to chronic pain, reduced mobility, and lost workdays. This is why access to high-quality, outcomes-driven MSK care matters now more than ever.
At HOPCo, we partner with healthcare practices to deliver evidence-based MSK care pathways that improve outcomes and lower costs. We do this by standardizing best practices, leveraging advanced analytics, and equipping clinicians with innovative tools that enhance patient engagement.
For example:
- Care pathway management platforms help ensure consistent, evidence-based treatment plans.
- Predictive analytics dashboards identify high-risk patients early, enabling timely interventions.
- Patient engagement apps keep patients informed and connected throughout their care journey.
From conservative management to advanced surgical interventions, our solutions help patients receive the right care at the right time so they can return to their daily lives faster and with less pain.
Arthritis and other MSK conditions are widespread, but innovation in care delivery is changing the game. HOPCo’s model integrates advanced analytics, digital engagement tools, and evidence-based pathways to do more than treat symptoms, it restores function and elevates quality of life. By combining technology with clinical expertise, we create a smarter, more connected system that benefits patients, providers, and the entire healthcare ecosystem.
Learn more about how HOPCo supports practices and patients in achieving better MSK outcomes. *Note: The full article is behind a paywall and requires a subscription to Medscape.